Drug Profile
Research programme: human protein therapeutics - Klotho therapeutics
Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator Klotho Therapeutics
- Class Enzymes; Proteins
- Mechanism of Action TRPC6 cation channel modulators; TRPV cation channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Cognition disorders; Diabetes mellitus; Kidney disorders
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for research development in Cancer in USA
- 28 Dec 2021 No recent reports of development identified for research development in Cognition-disorders in USA
- 28 Dec 2021 No recent reports of development identified for research development in Diabetes-mellitus in USA